Group Pushing FDA To Remove Birth Control Patch From Market

July 11, 2008

The Public Citizen's Health Research Group has sent a petition to the FDA, asking them to remove the Johnson & Johnson birth control patch Ortho Evra from the market due to an increased risk of blood clots.Washington (ChattahBox) – The Public Citizen’s Health Research Group has sent a petition to the FDA, asking them to remove the Johnson & Johnson birth control patch Ortho Evra from the market due to an increased risk of blood clots.

The Ortho Evra patch, which gives out estrogen, has been linked in the past to an increased risk of blood clots.

The group stated that some women absorb too much estrogen, putting them at a higher risk for these potentially fatal blood clots.

The head of the research group, Sidney Wolfe, stated “The considerable safety concern of high-dose, variable estrogen exposure tips the balance of risks and benefits against the availability of Ortho Evra as a contraceptive.”

A previous study stated that those at highest risk were between the ages of 15 and 44-years old.

The FDA has yet to respond to the call by the group.


Comments

Comments are closed.